Navigation Links
Seven Poster Abstracts Highlight MiMedx Allografts at the 10th Annual Desert Foot Conference
Date:11/26/2013

MARIETTA, Ga., Nov. 26, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today the summaries of a selection of the seven posters highlighting MiMedx allografts presented at the recent 10th Annual Desert Foot High Risk Diabetic Foot Conference in Phoenix, Arizona.

The posters chronicled the clinical effectiveness of the MiMedx dehydrated human amnion/chorion membrane ("dHACM") allografts and detailed a wide range of wounds and injuries with varying degrees of etiologies.  A sampling of the posters presenting dHACM cases and studies, along with a summary of the respective study results and conclusions are as follows:

  • EpiFix Utilization for Advanced Wound Therapy in an Evidence Based Approach to Treat Foot Ulcers.
    • Results: 10 non-healing diabetic foot ulcers (DFUs) and 3 pressure ulcers were treated with EpiFix®. 75% of the ulcers healed with EpiFix® at an average healing time of 11.7 weeks after 3.5 applications. Complete healing occurred in 67% of the DFUs and 100% of pressure ulcers. Of the 3 DFUs not healing 100%, 2 were non-compliant and one had foot deformity issues prior to the study causing discontinuation of the graft.
    • Conclusion: Multiple advantages were noted in using EpiFix® to treat non-healing wounds in the VA clinic setting including ease of use and availability of multiple graft sizes to minimize waste. With adequate wound debridement and proper wound bed maintenance, a 75% healing rate of non-healing foot ulcers was achieved with the utilization of EpiFix®.
  • '/>"/>

SOURCE MiMedx Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Seventh Sense Biosystems Receives CE Mark Approval for its Touch Activated Phlebotomy Blood Collection and Testing System
2. FDAnews Announces Leading the Climb: Seven Essentials of GMP Workshop
3. Hyland Software Hosts Seventh Annual OnBase/Epic User Forum
4. MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting
5. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
6. AUL Files Seventh Brief Supporting First Amendment Freedom of Conscience
7. Volcano Corporation Announces Webcast Of March Seventh Analyst Day
8. Seven Denver Area Hospitals Join Colorado Health Information Exchange To Support Advancements In Health Care Quality & Safety
9. MetroStar Home Health Medical Equipment Holds Seven-Day Disaster Relief Drive
10. Seven More Plaintiffs Sue Stryker over Defective Hip Implant Devices
11. Wave of Celebrity Support Boosts Global Effort to Eliminate Seven Diseases by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  DURECT Corporation (Nasdaq: DRRX ) ... successful completion of a Phase 1 clinical trial ... is an endogenous, small-molecule, new chemical entity (NCE), ... such as nonalcoholic fatty liver disease (NAFLD) and ... such as acute kidney injury (AKI).        ...
(Date:3/2/2015)... March 2, 2015 BD (Becton, Dickinson and ... medical technology company, today announced the acquisition of CRISI ... medical technology company dedicated to improving the safety and ... position in helping address preventable medication errors and improve ... into an exclusive partnership in June 2013 to jointly ...
(Date:3/2/2015)...  Akron Children,s Hospital has been designated a Diagnostic ... of Radiology (ACR), making it the first hospital in ... hospital in the United States ... from the ACR as a DICOE provides validation that ... with national benchmarks," says Dr. Michael Rubin , ...
Breaking Medicine Technology:DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2
...  Mission Pharmacal Company announces the recent formation ... unit, a wholly owned subsidiary of Mission, ... and human resources (HR) support.  Alamo will ... Northeastern United States presence, which also includes ...
... (NYSE: WPI ) today announced that ... a settlement with Mallinckrodt Inc. on outstanding patent ... Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt filed ... United States District Court for the District of ...
Cached Medicine Technology:Mission Pharmacal Launches Alamo Pharma Services 2Mission Pharmacal Launches Alamo Pharma Services 3Watson Reaches Settlement with Mallinckrodt Over Exalgo(R) 2
(Date:3/2/2015)... March 02, 2015 Doctors in Novara, ... a better predictor of outcomes for people with mesothelioma ... details of the new study on the Surviving ... the University of Eastern Piedmont followed the cases of ... treatment for excess lung fluid. , “Persistent lung ...
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... Over the last five years the ultrasound market has ... their geographic presence and achieve economies of scale. The ... by 2019 at CAGR of 5.1% from 2014 to ... and a major part of Europe are mature markets ... including China and India, Latin America and the Middle ...
(Date:3/2/2015)... LegitScript, LLC, operator of ... including those for Internet pharmacy certification, monitoring ... classification, has launched a certification program for ... program, called iCareRx , provides certification ... identity of the owner/operator of Internet websites, ...
(Date:3/2/2015)... Pleasant Prairie, WI (PRWEB) March 02, 2015 ... life sciences consultancy focused on quality, regulatory and ... a role as Chief Operating Officer. , ... years of experience leading R&D teams in all ... has held leadership positions at Covidien (Medtronic), Regulatory ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2
... The National Osteoporosis,Foundation (NOF) has partnered with CESLIE ... the LeFrak women - a dynamic mother-daughter trio ... dedication to,osteoporosis prevention. Joan Rivers, Melissa Rivers, Jill ... Walsh and Ceslie,Armstrong will host the cocktail soiree ...
... Charitable Contributions Decline Even Though Everyone Benefits ... And Don,t Forget to Claim The Deduction!, NEW YORK, April ... season, is a timely reminder that donating your car is,still a ... seem,to know that because the number of vehicle donations has plummeted ...
... policies could protect patients and physicians from consequences of ... offices and clinics can help prevent the abuse of ... following a stricter policy -- including urine testing --- ... , Implementing a user registry and educating medical staff ...
... British Columbia, April 10 On July,6, 2006, Current ... to the Chairman and to the Chief Executive,Officer, for ... capital of the Company, from his personal holdings, under ... total number of shares under option -- 3,000,000; ...
... Board Expanded to Seven Members, DALLAS, April ... leading healthcare staffing company, today said,that its Board ... (Jay),Dunn to its Board of Directors, effective immediately. ... seven members., John Kaiser, Crdentia,s President and ...
... Receive Grants from Largest and First-of-Its-Kind Fund in ... ... safety and quality of care, Cardinal Health announced,today grants totaling $1 million ... clinics across the country.,This program is the largest and first of its ...
Cached Medicine News:Health News:National Osteoporosis Foundation and CESLIE - The Women's Network Honor LeFrak Mother and Daughters for Commitment to Bone Health and New York Community 2Health News:Tax Season Reminder: Vehicle Donations Still Needed 2Health News:User Registry May Help Docs Stem Painkiller Abuse 2Health News:Keith Denner Extends Current Technology's Chairman and CEO Options 2Health News:Keith Denner Extends Current Technology's Chairman and CEO Options 3Health News:Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors 2Health News:Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors 3Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 2Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 3Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 4Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 5Health News:Cardinal Health Awards $1 Million to Fund Patient Safety Initiatives 6
... ACULAR® ophthalmic solution is a prescription ... instruct you to use after your ... eyes and may cause them to ... symptoms of inflammation include redness and ...
Mid-level interpretive resting ECG...
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
... Stat Profile pHOx series consists of six analyzer ... critical care profiles. Measured tests include pH, PCO ... hematocrit, hemoglobin, sodium, potassium, ionized calcium, chloride, glucose, ... than one minute. Its space saving design provides ...
Medicine Products: